SEC filings · customer concentration

Who depends on Ber Gen Bio AS

Ber Gen Bio AS appears in 1 disclosed customer relationships between 2011 and 2020.

0major customers now
—of revenue from them
0listed suppliers depending on it
2011–2020years covered
Free

Get an email when Ber Gen Bio AS's customer concentration changes

When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.

Suppliers that depend on Ber Gen Bio AS

Listed companies whose annual report names Ber Gen Bio AS as a customer worth 10% or more of their revenue. If Ber Gen Bio AS cuts orders or switches supplier, these are the companies that feel it.

Formerly disclosed

SupplierIts revenue from this companyChange vs prior yearHistoryLatest filing
Rigel PharmaceuticalsRIGL74%last FY 2017FY 2011: 11%FY 2012: 22%FY 2016: 18%FY 2017: 74%4 yearsFY 2017 · filed 27 Feb 2020

About this data

US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.

All companies · Latest dependency shifts · Bulk data and API